Target intelligence / Profile preview

Solute carrier family 35 member E1 (SLC35E1)

Target
SLC35E1
Molecular classification
Transporter, Solute carrier family protein, Membrane protein
01

Overview

Solute carrier family 35 member E1 (SLC35E1) is a hydrophobic membrane protein belonging to the SLC35 subfamily of the SLC transporter superfamily[2]. The SLC35 family primarily comprises nucleotide sugar transporters that mediate the transport of nucleotide sugars and adenosine 3'-phospho 5'-phosphosulfate from the cytosol to the endoplasmic reticulum and Golgi apparatus, supporting proper glycosylation and sulfation of proteins, lipids, and proteoglycans[2]. Unlike well-characterized SLC35 members, the exact substrate and transport function for SLC35E1 remain unidentified; however, it is highly conserved, and mutations in key substrate-binding residues (e.g., lysine 142) impair its function[2]. Functionally, SLC35E1 has been shown to play a role in nuclear egress of virions during HSV-1 infection, meaning it facilitates the release of viral particles from the infected cell nucleus[2]. While related families are validated drug targets, and SLC proteins comprise ~20% of all membrane proteins, there are no drugs or biomarker applications specific to SLC35E1 at this time[2][1]. SLC35E1 is therefore best classified as a potential transporter and an accessory viral effector protein, with growing interest in its role in viral infection biology and possible involvement in glycosylation pathways, but with limited data on its therapeutic targeting, endogenous substrates, or disease implications outside of viral infection[2].

Other names
SLC35E1PSEC0038FLJ14251
02

Biological functions

Likely nucleotide sugar transport (by analogy to SLC35 family members, but substrate is not identified)Putative role in glycosylation and sulfation of proteins and lipids (by family association)Involved in nuclear egress of herpes simplex virus type 1 (HSV-1), specifically facilitating viral de-envelopment from the nuclear membrane
03

Disease associations

May play a role in infection (HSV-1 egress from nucleus)Other: insufficient evidence for roles in cancer, inflammation, or other diseases

Beyond the preview

Go deeper on Solute carrier family 35 member E1 (SLC35E1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 35 member E1 (SLC35E1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call